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To explore HIV-1 group O genetic diversity and evolution through the largest series of HIV-O
sequences, from Cameroon (samples used for HIV-O diagnosis and follow-up in the Centre
Pasteur du Cameroun), France (RES-O surveillance network of the HIV National Reference
Center) and Gabon.
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OBJECTIVE
METHODS
Sampling times ranging from 1987 to 2012 (25 years)
Three genome regions amplified, sequenced and concatenated
(2012 bp)
190 patients: 102 from France + 87 from Cameroon + 1 from Gabon
HIV-1 is subdivided into 4 groups: M, O,
N and P.
Each group represents an independent
cross-species transmission of SIV
(Simian Immunodeficiency Viruses) to
humans.
Group M is pandemic : >34,000,000
infections worldwide;
Groups N and P very rare: <20
infections linked to Cameroon;
Group O is endemic in Cameroon: ~
10,000 to 30,000 infections.
Group O MRCA (Most Recent Common
Ancestor) has been estimated to be as
ancient as group M based on few
sequences available. But group O
genetic diversity and evolution remains
poorly characterized.
RESULTS
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HIV-1 group O ML tree topology is
atypical, with a predominant clade
emerging from and broad and
genetically diverse base population.
The natural presence of the Y181C
mutation, conferring resistance to
NNRTIs, is significantly associated to
the emergent clade (p<0.01).
Sequence from NNRTI-naive patient with 181C residue
Sequence from NNRTI-naive patient with 181Y residue
Sequence from NNRTI-treated patient or no data on ARV treatment
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HIV-1 group O MRCA is estimated
around 1930 (black curves). The
predominant clade is more
recent, with a MRCA estimate
around 1960 (blue curves).
Several subclusters emerged even
more recently, in the 1980’s
(yellow, green and red curves).
HIV-1 group O diversification went through two exponential phases, in the 1950’s and in the 1980’s.
The now predominant population arose during the second phase, from an ancestral level of genetic diversity which had
developed during the first diversification wave.
According to the historical context in Cameroon, the 1st wave might have been favored by iatrogenic routes of transmission in
the 1950’s, while the second would have benefited from the development of urbanization.
CONCLUSIONS
HIV-1 groups M and O share a similar age but group O has remained largely confined to Cameroon.
Group O local diversification resulted in a broad genetic diversity that cannot be compared to group M subtypes. However, two subgroups can be observed,
corresponding to two successive phases of diversification.
The viral properties of the two subgroups need to be investigated, in order to better understand why the most recent population to emerge has now become predominant.
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